pyrazines has been researched along with pteridines in 18 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (61.11) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (5.56) | 29.6817 |
2010's | 5 (27.78) | 24.3611 |
2020's | 1 (5.56) | 2.80 |
Authors | Studies |
---|---|
Bonner, JT; Hall, EM; Pan, P | 1 |
Kubo, S; Takamatsu, Y; Tanabe, T; Uesaka, I; Yamada, K | 1 |
Furumoto, S; Mitsuda, H; Suzuki, Y | 1 |
Haddow, A; Ross, WC; Timmis, GM | 1 |
Hieda, M; Yurugi, S | 1 |
Albert, A; Ota, K | 1 |
Beach, RL; Plaut, GW | 1 |
Brade, W; Propping, P | 1 |
Cragoe, EJ; Jones, JH | 1 |
Bicking, JB; Cragoe, EJ; Jones, JH | 1 |
Dneprovskaia, E; Doukas, J; Fine, RM; Hood, J; Kang, X; Lohse, D; Martin, M; Noronha, G; Palanki, MS; Soll, RM; Wrasidlo, W; Yee, S; Zhu, H | 1 |
CAIN, CK; MALLETTE, MF; TAYLOR, EC | 1 |
Feng, Y; Lee, J; Liu, ZJ; Titushin, MS; Vysotski, ES | 1 |
Elemento, O; Houghtaling, BR; Kapoor, TM; Wacker, SA | 1 |
Arvanitis, AG; Bronson, JJ; Combs, AP; Dasgupta, B; Dzierba, CD; Galka, A; Gilligan, PJ; Johnson, TL; Kasireddy-Polam, P; Lodge, NJ; Macor, JE; Molski, TF; Rafalski, M; Sielecki, TM; Takvorian, AG; Trainor, GL; Vig, S; Wong, H; Zaczek, RC; Zhang, G | 1 |
Bertomeu, T; Bucur, O; Dewar, R; Goganau, I; Khosravi-Far, R; Pennarun, B; Petrescu, SM; Stancu, AL | 1 |
Klewe, A; Kruse, T; Lindel, T | 1 |
Classe, JM; Ferron, G; Floquet, A; Freyer, G; Hardy-Bessard, AC; Kurtz, JE; Lécuru, F; Motte-Rouge, T; Pautier, P | 1 |
2 review(s) available for pyrazines and pteridines
Article | Year |
---|---|
Protein-protein complexation in bioluminescence.
Topics: Animals; Anthozoa; Aquatic Organisms; Bacteria; Binding Sites; Calcium; Crystallography, X-Ray; Fluorescence Resonance Energy Transfer; Green Fluorescent Proteins; Hydrozoa; Imidazoles; Luciferases; Luminescent Measurements; Luminescent Proteins; Models, Molecular; Protein Binding; Pteridines; Pyrazines; Scyphozoa; Spectrometry, Fluorescence | 2011 |
Prise en charge médicale de la récidive du cancer épithélial de l'ovaire: Medical management of recurrent epithelial ovarian cancer.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Azepines; Bevacizumab; Carcinoma, Ovarian Epithelial; Female; Genes, BRCA1; Genes, BRCA2; Humans; Immunoconjugates; Immunotherapy; Isoxazoles; Maintenance Chemotherapy; Maytansine; Neoplasm Recurrence, Local; Ovarian Neoplasms; Platinum Compounds; Poly(ADP-ribose) Polymerase Inhibitors; Pteridines; Pyrazines; Pyrimidines | 2021 |
16 other study(ies) available for pyrazines and pteridines
Article | Year |
---|---|
Determination of the active portion of the folic acid molecule in cellular slime mold chemotaxis.
Topics: Agar; Aminobenzoates; Biological Assay; Cell-Free System; Cellophane; Chemical Phenomena; Chemistry; Chemotaxis; Chromatography, Thin Layer; Cyclic AMP; Drug Synergism; Folic Acid; Glutamates; Myxomycetes; Pteridines; Pyrazines; Pyrimidines; Species Specificity | 1975 |
[Studies on diazabicycloalkanes. I. Pharmacological studies of octahydro-2H-pyrido(1,2-a)pyrazine derivatives and related compounds, especially their antihistaminic activities].
Topics: Anesthetics, Local; Animals; Barium; Female; Guinea Pigs; Histamine H1 Antagonists; Ileum; In Vitro Techniques; Male; Muscle, Smooth; Parasympatholytics; Pteridines; Pyrazines; Pyridines; Rats; Serotonin Antagonists; Structure-Activity Relationship | 1972 |
An extreme diminution in the strong affinity of 2-amino-4-hydroxy-6-formylpteridine for xanthine oxidase by reduction of a 7, 8-double bond or a formyl group at position 6 of its pyrazine ring.
Topics: Amines; Animals; Binding Sites; Binding, Competitive; Kinetics; Mathematics; Milk; Models, Chemical; Oxidation-Reduction; Polarography; Pteridines; Pyrazines; Structure-Activity Relationship; Xanthine Oxidase; Xanthines | 1974 |
The chain of unexpected discovery: xanthopterin-stimulated renal mitosis.
Topics: Animals; Biochemistry; Creativity; History, 20th Century; Hyperplasia; Hypertrophy; Hypoxanthines; Kidney; Kidney Diseases; Mitosis; Pteridines; Purines; Pyrazines; Pyrimidines; Quinoxalines; Rats; Stimulation, Chemical; Structure-Activity Relationship; United Kingdom; Xanthine Oxidase; Xanthopterin | 1972 |
[Studies on the syntheses of N-heterocyclic compounds. X. Syntheses of 2-phenyl-pyrazino(2,3-d)pyridazine derivatives].
Topics: Chemical Phenomena; Chemistry; Pteridines; Pyrazines; Pyridazines | 1972 |
Pteridine studies. XLI. New routes to 4-aminopteridines via 3-(dimethylaminomethyleneamino)pyrazine-2-carbonitrile and related compounds.
Topics: Amines; Methods; Nitriles; Pteridines; Pyrazines | 1971 |
Investigations of structures of substituted lumazines by deuterium exchange and nuclear magnetic resonance spectroscopy.
Topics: Chemical Phenomena; Chemistry; Chromatography, Paper; Deuterium; Hot Temperature; Hydrogen-Ion Concentration; Magnetic Resonance Spectroscopy; Pteridines; Pyrazines; Spectrophotometry; Water | 1970 |
[Acute renal failure after pteridine administration].
Topics: Acute Kidney Injury; Animals; Anuria; Chlorothiazide; Diuretics; Folic Acid; Furosemide; Glomerular Filtration Rate; Kidney Function Tests; Kidney Tubules; Male; Pteridines; Pyrazines; Rats; Water-Electrolyte Balance; Xanthopterin | 1970 |
Pyrazine diuretics. V. N-Amidino-3-aminopyrazinecarboxamidines and analogous 2,4-diaminopteridines.
Topics: Adrenal Glands; Adrenalectomy; Animals; Chemical Phenomena; Chemistry, Physical; Diuretics; Dogs; Pteridines; Pyrazines; Rats; Spironolactone; Triamterene | 1968 |
Pyrazine diuretics. IV. N-amidino-3-amino-6-substituted pyrazinecarboxamides.
Topics: Amides; Animals; Carbon; Diuretics; Hydrogen; Nitrogen; Pteridines; Pyrazines; Rats | 1967 |
Discovery of 3,3'-(2,4-diaminopteridine-6,7-diyl)diphenol as an isozyme-selective inhibitor of PI3K for the treatment of ischemia reperfusion injury associated with myocardial infarction.
Topics: Animals; Antigens, CD; Cadherins; Capillary Permeability; Cell Proliferation; Cells, Cultured; Endothelial Cells; Humans; Isoenzymes; Male; Models, Molecular; Myocardial Infarction; Myocardial Reperfusion Injury; Phenols; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Pteridines; Pyrazines; Pyridines; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Umbilical Veins; Vascular Endothelial Growth Factor A | 2007 |
Pyrimido [4,5-b]pyrazines (pteridines) pteridinemono- and -dicarboxylic acids.
Topics: Dicarboxylic Acids; Pteridines; Pyrazines | 1948 |
Using transcriptome sequencing to identify mechanisms of drug action and resistance.
Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Cell Cycle Proteins; Cell Line, Tumor; Drug Resistance, Neoplasm; Humans; Polo-Like Kinase 1; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Pteridines; Pyrazines; Sequence Analysis, DNA; Transcriptome | 2012 |
Synthesis and structure-activity relationships of pyrido[3,2-b]pyrazin-3(4H)-ones and pteridin-7(8H)-ones as corticotropin-releasing factor-1 receptor antagonists.
Topics: Animals; Anti-Anxiety Agents; Half-Life; Pteridines; Pyrazines; Rats; Receptors, Corticotropin-Releasing Hormone; Structure-Activity Relationship | 2012 |
Combination of bortezomib and mitotic inhibitors down-modulate Bcr-Abl and efficiently eliminates tyrosine-kinase inhibitor sensitive and resistant Bcr-Abl-positive leukemic cells.
Topics: Benzamides; Boronic Acids; Bortezomib; Caspases; Cell Death; Cell Line, Tumor; Dasatinib; Down-Regulation; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Activation; Fusion Proteins, bcr-abl; Heterocyclic Compounds, 2-Ring; Humans; Imatinib Mesylate; JNK Mitogen-Activated Protein Kinases; Leukemia; Mitosis; Models, Biological; p38 Mitogen-Activated Protein Kinases; Paclitaxel; Phosphorylation; Piperazines; Protein Kinase Inhibitors; Pteridines; Pyrazines; Pyrimidines; Signal Transduction; STAT5 Transcription Factor; Thiazoles | 2013 |
Aminopyrazine Pathway to the Moco Metabolite Dephospho Form A.
Topics: Coenzymes; Fungal Proteins; Metalloproteins; Molybdenum Cofactors; Neurospora crassa; Nitrate Reductase; Oxidation-Reduction; Pteridines; Pyrazines; Recombinant Proteins | 2017 |